ASTH Astrana Health PE ratio, current and historical analysis
The current PE ratio for Astrana Health stock as of Mar 11, 2025 is 21.53. This is calculated based on the TTM EPS of $1.31 and the stock price of $28.2 per share. The PE ratio marks a decrease of 36% from its last 4 quarters average of 33.4.
ASTH PE ratio history
The average historical PE ratio of Astrana Health for the last eight years is 39.29. The current P/E ratio of 21.53 is 45% lower than the historical average. Looking back at the last eight years, ASTH's PE ratio peaked in the Sep 2019 quarter at 160.18, when the price was $17.62 and the EPS was $0.11. The lowest point was in the Mar 2018 quarter, when it reached 17.72 with a price of $15.95 and an EPS of $0.9.
Astrana Health PE ratio by year
Maximum annual increase: 163.81% in 2021
Maximum annual decrease: -60.49% in 2020
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | 29.46 | -0.44% | $38.3 | $1.3 |
| 2022 | 29.59 | -36.77% | $29.59 | $1 |
| 2021 | 46.8 | 163.81% | $73.48 | $1.57 |
| 2020 | 17.74 | -60.49% | $18.27 | $1.03 |
| 2019 | 44.9 | -25.35% | $18.41 | $0.41 |
| 2018 | 60.15 | 153.16% | $19.85 | $0.33 |
| 2017 | 23.76 | N/A | $24 | $1.01 |
| 2016 | N/A | N/A | N/A | $0.46 |
| 2015 | N/A | N/A | N/A | -$0.37 |
| 2014 | N/A | N/A | N/A | -$1.37 |
| 2013 | N/A | N/A | N/A | -$2.7 |
| 2012 | N/A | N/A | N/A | -$0.2 |
| 2011 | N/A | N/A | N/A | -$0.1 |
| 2010 | N/A | N/A | N/A | -$0.1 |
| 2009 | N/A | N/A | N/A | -$0.4 |
Astrana Health PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | 44.23 | 57.01% | $57.94 | $1.31 |
| Jun 2024 | 28.17 | -11.44% | $40.56 | $1.44 |
| Mar 2024 | 31.81 | 7.98% | $41.99 | $1.32 |
| Dec 2023 | 29.46 | -10.24% | $38.3 | $1.3 |
| Sep 2023 | 32.82 | 2.82% | $30.85 | $0.94 |
| Jun 2023 | 31.92 | -14.22% | $31.6 | $0.99 |
| Mar 2023 | 37.21 | 25.75% | $36.47 | $0.98 |
| Dec 2022 | 29.59 | -2.12% | $29.59 | $1 |
| Sep 2022 | 30.23 | 20.63% | $39 | $1.29 |
| Jun 2022 | 25.06 | -19.34% | $38.59 | $1.54 |
| Mar 2022 | 31.07 | -33.61% | $48.47 | $1.56 |
| Dec 2021 | 46.8 | -16.22% | $73.48 | $1.57 |
| Sep 2021 | 55.86 | 17.4% | $91.05 | $1.63 |
| Jun 2021 | 47.58 | 116.08% | $62.81 | $1.32 |
| Mar 2021 | 22.02 | 24.13% | $27.09 | $1.23 |
ASTH average PE ratio chart
Currently, ASTH's PE ratio is lower than its 3 and 5-year averages.
ASTH PE vs peers
ASTH's PE ratio stands higher than its peer stock NHC.
| Stock name | PE ratio | Market cap |
|---|---|---|
| NHC National Healthcare Corp | 14.28 | $1.46B |
| ASTH Astrana Health Inc. | 21.53 | $1.59B |
| INNV InnovAge Holding Corp | N/A | $446.3M |
Frequently asked questions
What is Astrana Health's PE ratio?
As of Mar 11, 2025, ASTH stock has a price to earnings ratio of 21.53.
What is the 3-year average PE ratio for Astrana Health (ASTH)?
Over the last 3 years, the average price to earnings ratio for ASTH stock is 31.96.
What is the 5-year average PE ratio for Astrana Health (ASTH)?
Over the last 5 years, the average price to earnings ratio for ASTH stock is 32.19.
What is the highest PE ratio for ASTH?
Over the last eight years, the quarterly PE ratio reached its highest level at 160.18 in the Sep 2019 quarter.
How does the current PE ratio for ASTH compare to its historical average?
The current PE ratio of ASTH is 45% lower than the 8-year historical average.
How is ASTH's PE ratio calculated (Astrana Health PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Mar 11, 2025), Astrana Health's share price is $28.2. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.31. Therefore, Astrana Health's PE ratio for today is 21.53. PE RATIO(21.53) = STOCK PRICE($28.2) / TTM EPS($1.31)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.